Table of Content

1 Report Overview
1.1 Fexofenadine Definition
1.2 Market by Type
1.2.1 Global Fexofenadine Market Size Growth Rate by Type, 2018 VS 2024 VS 2034
1.2.2 Purity:98%
1.2.3 Purity:Above 98%
1.3 Market Segment by Application
1.3.1 Global Fexofenadine Market Size Growth Rate by Application, 2018 VS 2024 VS 2034
1.3.2 Hay Fever Treatment
1.3.3 Urticaria Treatment
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Fexofenadine Sales
2.1 Global Fexofenadine Revenue Estimates and Forecasts 2018-2034
2.2 Global Fexofenadine Revenue by Region: 2018 VS 2024 VS 2034
2.3 Global Fexofenadine Revenue by Region
2.3.1 Global Fexofenadine Revenue by Region (2018-2023)
2.3.2 Global Fexofenadine Revenue by Region (2024-2034)
2.4 Global Fexofenadine Sales Quantity Estimates and Forecasts 2018-2034
2.5 Global Fexofenadine Sales Quantity by Region: 2018 VS 2024 VS 2034
2.6 Global Fexofenadine Sales Quantity by Region
2.6.1 Global Fexofenadine Sales Quantity by Region (2018-2023)
2.6.2 Global Fexofenadine Sales Quantity by Region (2024-2034)
2.7 North America
2.8 Europe
2.9 China
2.10 APAC (excluding China)
2.11 Middle East, Africa and Latin America
3 Competition by Manufacturers
3.1 Global Fexofenadine Sales Quantity by Manufacturers
3.1.1 Global Fexofenadine Sales Quantity by Manufacturers (2018-2023)
3.1.2 Global Fexofenadine Sales Quantity Share by Manufacturers (2018-2023)
3.1.3 Global Top 10 and Top 5 Companies by Fexofenadine Sales in 2024
3.2 Global Fexofenadine Revenue by Manufacturers
3.2.1 Global Fexofenadine Revenue by Manufacturers (2018-2023)
3.2.2 Global Fexofenadine Revenue Share by Manufacturers (2018-2023)
3.2.3 Global Top 10 and Top 5 Companies by Fexofenadine Revenue in 2024
3.3 Global Fexofenadine Sales Price by Manufacturers
3.4 Global Key Players of Fexofenadine, Industry Ranking, 2021 VS 2024
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Fexofenadine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Fexofenadine, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Fexofenadine, Product Offered and Application
3.8 Global Key Manufacturers of Fexofenadine, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Estimates and Forecasts by Type
4.1 Global Fexofenadine Sales Quantity by Type
4.1.1 Global Fexofenadine Historical Sales Quantity by Type (2018-2023)
4.1.2 Global Fexofenadine Forecasted Sales Quantity by Type (2024-2034)
4.1.3 Global Fexofenadine Sales Quantity Market Share by Type (2018-2034)
4.2 Global Fexofenadine Revenue by Type
4.2.1 Global Fexofenadine Historical Revenue by Type (2018-2023)
4.2.2 Global Fexofenadine Forecasted Revenue by Type (2024-2034)
4.2.3 Global Fexofenadine Revenue Market Share by Type (2018-2034)
4.3 Global Fexofenadine Price by Type
4.3.1 Global Fexofenadine Price by Type (2018-2023)
4.3.2 Global Fexofenadine Price Forecast by Type (2024-2034)
5 Market Size by Application
5.1 Global Fexofenadine Sales Quantity by Application
5.1.1 Global Fexofenadine Historical Sales Quantity by Application (2018-2023)
5.1.2 Global Fexofenadine Forecasted Sales Quantity by Application (2024-2034)
5.1.3 Global Fexofenadine Sales Quantity Market Share by Application (2018-2034)
5.2 Global Fexofenadine Revenue by Application
5.2.1 Global Fexofenadine Historical Revenue by Application (2018-2023)
5.2.2 Global Fexofenadine Forecasted Revenue by Application (2024-2034)
5.2.3 Global Fexofenadine Revenue Market Share by Application (2018-2034)
5.3 Global Fexofenadine Price by Application
5.3.1 Global Fexofenadine Price by Application (2018-2023)
5.3.2 Global Fexofenadine Price Forecast by Application (2024-2034)
6 North America
6.1 North America Fexofenadine Sales by Company
6.1.1 North America Fexofenadine Revenue by Company (2018-2023)
6.1.2 North America Fexofenadine Sales Quantity by Company (2018-2023)
6.2 North America Fexofenadine Market Size by Type
6.2.1 North America Fexofenadine Sales Quantity by Type (2018-2034)
6.2.2 North America Fexofenadine Revenue by Type (2018-2034)
6.3 North America Fexofenadine Market Size by Application
6.3.1 North America Fexofenadine Sales Quantity by Application (2018-2034)
6.3.2 North America Fexofenadine Revenue by Application (2018-2034)
6.4 North America Fexofenadine Market Size by Country
6.4.1 North America Fexofenadine Revenue by Country: 2018 VS 2024 VS 2034
6.4.2 North America Fexofenadine Revenue by Country (2018-2034)
6.4.3 North America Fexofenadine Sales Quantity by Country (2018-2034)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Fexofenadine Sales by Company
7.1.1 Europe Fexofenadine Sales Quantity by Company (2018-2023)
7.1.2 Europe Fexofenadine Revenue by Company (2018-2023)
7.2 Europe Fexofenadine Market Size by Type
7.2.1 Europe Fexofenadine Sales Quantity by Type (2018-2034)
7.2.2 Europe Fexofenadine Revenue by Type (2018-2034)
7.3 Europe Fexofenadine Market Size by Application
7.3.1 Europe Fexofenadine Sales Quantity by Application (2018-2034)
7.3.2 Europe Fexofenadine Revenue by Application (2018-2034)
7.4 Europe Fexofenadine Market Size by Country
7.4.1 Europe Fexofenadine Revenue by Country: 2018 VS 2024 VS 2034
7.4.2 Europe Fexofenadine Revenue by Country (2018-2034)
7.4.3 Europe Fexofenadine Sales Quantity by Country (2018-2034)
7.4.4 Germany
7.4.5 France
7.4.6 U.K.
7.4.7 Italy
7.4.8 Russia
8 China
8.1 China Fexofenadine Sales by Company
8.1.1 China Fexofenadine Sales Quantity by Company (2018-2023)
8.1.2 China Fexofenadine Revenue by Company (2018-2023)
8.2 China Fexofenadine Market Size by Type
8.2.1 China Fexofenadine Sales Quantity by Type (2018-2034)
8.2.2 China Fexofenadine Revenue by Type (2018-2034)
8.3 China Fexofenadine Market Size by Application
8.3.1 China Fexofenadine Sales Quantity by Application (2018-2034)
8.3.2 China Fexofenadine Revenue by Application (2018-2034)
9 APAC (excluding China)
9.1 APAC Fexofenadine Sales by Company
9.1.1 APAC Fexofenadine Sales Quantity by Company (2018-2023)
9.1.2 APAC Fexofenadine Revenue by Company (2018-2023)
9.2 APAC Fexofenadine Market Size by Type
9.2.1 APAC Fexofenadine Sales Quantity by Type (2018-2034)
9.2.2 APAC Fexofenadine Revenue by Type (2018-2034)
9.3 APAC Fexofenadine Market Size by Application
9.3.1 APAC Fexofenadine Sales Quantity by Application (2018-2034)
9.3.2 APAC Fexofenadine Revenue by Application (2018-2034)
9.4 APAC Fexofenadine Market Size by Region
9.4.1 APAC Fexofenadine Revenue by Region: 2018 VS 2024 VS 2034
9.4.2 APAC Fexofenadine Revenue by Region (2018-2034)
9.4.3 APAC Fexofenadine Sales Quantity by Region (2018-2034)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Fexofenadine Sales by Company
10.1.1 Middle East, Africa and Latin America Fexofenadine Sales Quantity by Company (2018-2023)
10.1.2 Middle East, Africa and Latin America Fexofenadine Revenue by Company (2018-2023)
10.2 Middle East, Africa and Latin America Fexofenadine Market Size by Type
10.2.1 Middle East, Africa and Latin America Fexofenadine Sales Quantity by Type (2018-2034)
10.2.2 Middle East, Africa and Latin America Fexofenadine Revenue by Type (2018-2034)
10.3 Middle East, Africa and Latin America Fexofenadine Market Size by Application
10.3.1 Middle East, Africa and Latin America Fexofenadine Sales Quantity by Application (2018-2034)
10.3.2 Middle East, Africa and Latin America Fexofenadine Revenue by Application (2018-2034)
10.4 Middle East, Africa and Latin America Fexofenadine Market Size by Country
10.4.1 Middle East, Africa and Latin America Fexofenadine Revenue by Country: 2018 VS 2024 VS 2034
10.4.2 Middle East, Africa and Latin America Fexofenadine Revenue by Country (2018-2034)
10.4.3 Middle East, Africa and Latin America Fexofenadine Sales Quantity by Country (2018-2034)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Israel
10.4.8 GCC Countries
11 Company Profiles
11.1 Viruj Pharma
11.1.1 Viruj Pharma Company Information
11.1.2 Viruj Pharma Overview
11.1.3 Viruj Pharma Fexofenadine Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.1.4 Viruj Pharma Fexofenadine Products and Services
11.1.5 Viruj Pharma Fexofenadine SWOT Analysis
11.1.6 Viruj Pharma Recent Developments
11.2 Cemex Pharma
11.2.1 Cemex Pharma Company Information
11.2.2 Cemex Pharma Overview
11.2.3 Cemex Pharma Fexofenadine Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.2.4 Cemex Pharma Fexofenadine Products and Services
11.2.5 Cemex Pharma Fexofenadine SWOT Analysis
11.2.6 Cemex Pharma Recent Developments
11.3 Smaart Pharmaceutticals
11.3.1 Smaart Pharmaceutticals Company Information
11.3.2 Smaart Pharmaceutticals Overview
11.3.3 Smaart Pharmaceutticals Fexofenadine Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.3.4 Smaart Pharmaceutticals Fexofenadine Products and Services
11.3.5 Smaart Pharmaceutticals Fexofenadine SWOT Analysis
11.3.6 Smaart Pharmaceutticals Recent Developments
11.4 Titan Pharma
11.4.1 Titan Pharma Company Information
11.4.2 Titan Pharma Overview
11.4.3 Titan Pharma Fexofenadine Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.4.4 Titan Pharma Fexofenadine Products and Services
11.4.5 Titan Pharma Fexofenadine SWOT Analysis
11.4.6 Titan Pharma Recent Developments
11.5 AFCL
11.5.1 AFCL Company Information
11.5.2 AFCL Overview
11.5.3 AFCL Fexofenadine Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.5.4 AFCL Fexofenadine Products and Services
11.5.5 AFCL Fexofenadine SWOT Analysis
11.5.6 AFCL Recent Developments
11.6 Synkromax
11.6.1 Synkromax Company Information
11.6.2 Synkromax Overview
11.6.3 Synkromax Fexofenadine Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.6.4 Synkromax Fexofenadine Products and Services
11.6.5 Synkromax Fexofenadine SWOT Analysis
11.6.6 Synkromax Recent Developments
11.7 Farmhispania
11.7.1 Farmhispania Company Information
11.7.2 Farmhispania Overview
11.7.3 Farmhispania Fexofenadine Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.7.4 Farmhispania Fexofenadine Products and Services
11.7.5 Farmhispania Fexofenadine SWOT Analysis
11.7.6 Farmhispania Recent Developments
11.8 Gen Pharma
11.8.1 Gen Pharma Company Information
11.8.2 Gen Pharma Overview
11.8.3 Gen Pharma Fexofenadine Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.8.4 Gen Pharma Fexofenadine Products and Services
11.8.5 Gen Pharma Fexofenadine SWOT Analysis
11.8.6 Gen Pharma Recent Developments
11.9 Admiron Life Sciences Private Limited
11.9.1 Admiron Life Sciences Private Limited Company Information
11.9.2 Admiron Life Sciences Private Limited Overview
11.9.3 Admiron Life Sciences Private Limited Fexofenadine Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.9.4 Admiron Life Sciences Private Limited Fexofenadine Products and Services
11.9.5 Admiron Life Sciences Private Limited Fexofenadine SWOT Analysis
11.9.6 Admiron Life Sciences Private Limited Recent Developments
11.10 JRC
11.10.1 JRC Company Information
11.10.2 JRC Overview
11.10.3 JRC Fexofenadine Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.10.4 JRC Fexofenadine Products and Services
11.10.5 JRC Fexofenadine SWOT Analysis
11.10.6 JRC Recent Developments
11.11 Archerchem
11.11.1 Archerchem Company Information
11.11.2 Archerchem Overview
11.11.3 Archerchem Fexofenadine Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.11.4 Archerchem Fexofenadine Products and Services
11.11.5 Archerchem Recent Developments
11.12 Sibram
11.12.1 Sibram Company Information
11.12.2 Sibram Overview
11.12.3 Sibram Fexofenadine Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.12.4 Sibram Fexofenadine Products and Services
11.12.5 Sibram Recent Developments
11.13 Sumitomo Chemical
11.13.1 Sumitomo Chemical Company Information
11.13.2 Sumitomo Chemical Overview
11.13.3 Sumitomo Chemical Fexofenadine Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.13.4 Sumitomo Chemical Fexofenadine Products and Services
11.13.5 Sumitomo Chemical Recent Developments
11.14 Panchsheel
11.14.1 Panchsheel Company Information
11.14.2 Panchsheel Overview
11.14.3 Panchsheel Fexofenadine Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.14.4 Panchsheel Fexofenadine Products and Services
11.14.5 Panchsheel Recent Developments
11.15 CAMEO HEALTH CARE
11.15.1 CAMEO HEALTH CARE Company Information
11.15.2 CAMEO HEALTH CARE Overview
11.15.3 CAMEO HEALTH CARE Fexofenadine Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.15.4 CAMEO HEALTH CARE Fexofenadine Products and Services
11.15.5 CAMEO HEALTH CARE Recent Developments
11.16 CEPiA-Sanofi
11.16.1 CEPiA-Sanofi Company Information
11.16.2 CEPiA-Sanofi Overview
11.16.3 CEPiA-Sanofi Fexofenadine Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.16.4 CEPiA-Sanofi Fexofenadine Products and Services
11.16.5 CEPiA-Sanofi Recent Developments
11.17 Va Sudha Pharma Chem Limited
11.17.1 Va Sudha Pharma Chem Limited Company Information
11.17.2 Va Sudha Pharma Chem Limited Overview
11.17.3 Va Sudha Pharma Chem Limited Fexofenadine Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.17.4 Va Sudha Pharma Chem Limited Fexofenadine Products and Services
11.17.5 Va Sudha Pharma Chem Limited Recent Developments
11.18 VPL Chemicals
11.18.1 VPL Chemicals Company Information
11.18.2 VPL Chemicals Overview
11.18.3 VPL Chemicals Fexofenadine Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.18.4 VPL Chemicals Fexofenadine Products and Services
11.18.5 VPL Chemicals Recent Developments
11.19 Zhejiang Excel Pharmaceutical
11.19.1 Zhejiang Excel Pharmaceutical Company Information
11.19.2 Zhejiang Excel Pharmaceutical Overview
11.19.3 Zhejiang Excel Pharmaceutical Fexofenadine Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.19.4 Zhejiang Excel Pharmaceutical Fexofenadine Products and Services
11.19.5 Zhejiang Excel Pharmaceutical Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Fexofenadine Value Chain Analysis
12.2 Fexofenadine Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Fexofenadine Production Mode & Process
12.4 Fexofenadine Sales and Marketing
12.4.1 Fexofenadine Sales Channels
12.4.2 Fexofenadine Distributors
12.5 Fexofenadine Customers
13 Market Dynamics
13.1 Fexofenadine Industry Trends
13.2 Fexofenadine Market Drivers
13.3 Fexofenadine Market Challenges
13.4 Fexofenadine Market Restraints
14 Key Findings
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Fexofenadine Market Size Growth Rate (CAGR) by Type, 2018 VS 2024 VS 2034 (US$ Million)
Table 2. Major Manufacturers of Purity:98%
Table 3. Major Manufacturers of Purity:Above 98%
Table 4. Global Fexofenadine Market Size Growth Rate (CAGR) by Application, 2018 VS 2024 VS 2034 (US$ Million)
Table 5. Global Fexofenadine Revenue by Region: 2018 VS 2024 VS 2034 (US$ Million)
Table 6. Global Fexofenadine Revenue by Region (2018-2023) & (US$ Million)
Table 7. Global Fexofenadine Revenue Market Share by Region (2018-2023)
Table 8. Global Fexofenadine Revenue by Region (2024-2034) & (US$ Million)
Table 9. Global Fexofenadine Revenue Market Share by Region (2024-2034)
Table 10. Global Fexofenadine Sales Quantity by Region: 2018 VS 2024 VS 2034 (K Units)
Table 11. Global Fexofenadine Sales by Region (2018-2023) & (K Units)
Table 12. Global Fexofenadine Sales Market Share by Region (2018-2023)
Table 13. Global Fexofenadine Sales by Region (2024-2034) & (K Units)
Table 14. Global Fexofenadine Sales Market Share by Region (2024-2034)
Table 15. Global Fexofenadine Sales Quantity by Manufacturers (2018-2023) & (K Units)
Table 16. Global Fexofenadine Sales Quantity Share by Manufacturers (2018-2023)
Table 17. Global Fexofenadine Revenue by Manufacturers (2018-2023) & (US$ Million)
Table 18. Global Fexofenadine Revenue Share by Manufacturers (2018-2023)
Table 19. Global Fexofenadine Price by Manufacturers 2018-2023 (USD/Unit)
Table 20. Global Key Players of Fexofenadine, Industry Ranking, 2021 VS 2024
Table 21. Global Fexofenadine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Fexofenadine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Fexofenadine as of 2024)
Table 23. Global Key Manufacturers of Fexofenadine, Manufacturing Base Distribution and Headquarters
Table 24. Global Key Manufacturers of Fexofenadine, Product Offered and Application
Table 25. Global Key Manufacturers of Fexofenadine, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Fexofenadine Sales Quantity by Type (2018-2023) & (K Units)
Table 28. Global Fexofenadine Sales Quantity by Type (2024-2034) & (K Units)
Table 29. Global Fexofenadine Sales Quantity Share by Type (2018-2023)
Table 30. Global Fexofenadine Sales Quantity Share by Type (2024-2034)
Table 31. Global Fexofenadine Revenue by Type (2018-2023) & (US$ Million)
Table 32. Global Fexofenadine Revenue by Type (2024-2034) & (US$ Million)
Table 33. Global Fexofenadine Revenue Share by Type (2018-2023)
Table 34. Global Fexofenadine Revenue Share by Type (2024-2034)
Table 35. Fexofenadine Price by Type (2018-2023) & (USD/Unit)
Table 36. Global Fexofenadine Price Forecast by Type (2024-2034) & (USD/Unit)
Table 37. Global Fexofenadine Sales Quantity by Application (2018-2023) & (K Units)
Table 38. Global Fexofenadine Sales Quantity by Application (2024-2034) & (K Units)
Table 39. Global Fexofenadine Sales Quantity Share by Application (2018-2023)
Table 40. Global Fexofenadine Sales Quantity Share by Application (2024-2034)
Table 41. Global Fexofenadine Revenue by Application (2018-2023) & (US$ Million)
Table 42. Global Fexofenadine Revenue by Application (2024-2034) & (US$ Million)
Table 43. Global Fexofenadine Revenue Share by Application (2018-2023)
Table 44. Global Fexofenadine Revenue Share by Application (2024-2034)
Table 45. Fexofenadine Price by Application (2018-2023) & (USD/Unit)
Table 46. Global Fexofenadine Price Forecast by Application (2024-2034) & (USD/Unit)
Table 47. North America Fexofenadine Revenue by Company (2018-2023) & (US$ Million)
Table 48. North America Fexofenadine Sales Quantity by Company (2018-2023) & (K Units)
Table 49. North America Fexofenadine Sales Quantity by Type (2018-2023) & (K Units)
Table 50. North America Fexofenadine Sales Quantity by Type (2024-2034) & (K Units)
Table 51. North America Fexofenadine Revenue by Type (2018-2023) & (US$ Million)
Table 52. North America Fexofenadine Revenue by Type (2024-2034) & (US$ Million)
Table 53. North America Fexofenadine Sales Quantity by Application (2018-2023) & (K Units)
Table 54. North America Fexofenadine Sales Quantity by Application (2024-2034) & (K Units)
Table 55. North America Fexofenadine Revenue by Application (2018-2023) & (US$ Million)
Table 56. North America Fexofenadine Revenue by Application (2024-2034) & (US$ Million)
Table 57. North America Fexofenadine Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 58. North America Fexofenadine Revenue by Country (2018-2023) & (US$ Million)
Table 59. North America Fexofenadine Revenue by Country (2024-2034) & (US$ Million)
Table 60. North America Fexofenadine Sales Quantity by Country (2018-2023) & (K Units)
Table 61. North America Fexofenadine Sales Quantity by Country (2024-2034) & (K Units)
Table 62. Europe Fexofenadine Sales Quantity by Company (2018-2023) & (K Units)
Table 63. Europe Fexofenadine Revenue by Company (2018-2023) & (US$ Million)
Table 64. Europe Fexofenadine Sales Quantity by Type (2018-2023) & (K Units)
Table 65. Europe Fexofenadine Sales Quantity by Type (2024-2034) & (K Units)
Table 66. Europe Fexofenadine Revenue by Type (2018-2023) & (US$ Million)
Table 67. Europe Fexofenadine Revenue by Type (2024-2034) & (US$ Million)
Table 68. Europe Fexofenadine Sales Quantity by Application (2018-2023) & (K Units)
Table 69. Europe Fexofenadine Sales Quantity by Application (2024-2034) & (K Units)
Table 70. Europe Fexofenadine Revenue by Application (2018-2023) & (US$ Million)
Table 71. Europe Fexofenadine Revenue by Application (2024-2034) & (US$ Million)
Table 72. Europe Fexofenadine Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 73. Europe Fexofenadine Revenue by Country (2018-2023) & (US$ Million)
Table 74. Europe Fexofenadine Revenue by Country (2024-2034) & (US$ Million)
Table 75. Europe Fexofenadine Sales Quantity by Country (2018-2023) & (K Units)
Table 76. Europe Fexofenadine Sales Quantity by Country (2024-2034) & (K Units)
Table 77. China Fexofenadine Sales Quantity by Company (2018-2023) & (K Units)
Table 78. China Fexofenadine Revenue by Company (2018-2023) & (US$ Million)
Table 79. China Fexofenadine Sales Quantity by Type (2018-2023) & (K Units)
Table 80. China Fexofenadine Sales Quantity by Type (2024-2034) & (K Units)
Table 81. China Fexofenadine Revenue by Type (2018-2023) & (US$ Million)
Table 82. China Fexofenadine Revenue by Type (2024-2034) & (US$ Million)
Table 83. China Fexofenadine Sales Quantity by Application (2018-2023) & (K Units)
Table 84. China Fexofenadine Sales Quantity by Application (2024-2034) & (K Units)
Table 85. China Fexofenadine Revenue by Application (2018-2023) & (US$ Million)
Table 86. China Fexofenadine Revenue by Application (2024-2034) & (US$ Million)
Table 87. APAC Fexofenadine Sales Quantity by Company (2018-2023) & (K Units)
Table 88. APAC Fexofenadine Revenue by Company (2018-2023) & (US$ Million)
Table 89. APAC Fexofenadine Sales Quantity by Type (2018-2023) & (K Units)
Table 90. APAC Fexofenadine Sales Quantity by Type (2024-2034) & (K Units)
Table 91. APAC Fexofenadine Revenue by Type (2018-2023) & (US$ Million)
Table 92. APAC Fexofenadine Revenue by Type (2024-2034) & (US$ Million)
Table 93. APAC Fexofenadine Sales Quantity by Application (2018-2023) & (K Units)
Table 94. APAC Fexofenadine Sales Quantity by Application (2024-2034) & (K Units)
Table 95. APAC Fexofenadine Revenue by Application (2018-2023) & (US$ Million)
Table 96. APAC Fexofenadine Revenue by Application (2024-2034) & (US$ Million)
Table 97. APAC Fexofenadine Revenue by Region: 2018 VS 2024 VS 2034 (US$ Million)
Table 98. APAC Fexofenadine Revenue by Region (2018-2023) & (US$ Million)
Table 99. APAC Fexofenadine Revenue by Region (2024-2034) & (US$ Million)
Table 100. APAC Fexofenadine Sales Quantity by Region (2018-2023) & (K Units)
Table 101. APAC Fexofenadine Sales Quantity by Region (2024-2034) & (K Units)
Table 102. Middle East, Africa and Latin America Fexofenadine Sales Quantity by Company (2018-2023) & (K Units)
Table 103. Middle East, Africa and Latin America Fexofenadine Revenue by Company (2018-2023) & (US$ Million)
Table 104. Middle East, Africa and Latin America Fexofenadine Sales Quantity by Type (2018-2023) & (K Units)
Table 105. Middle East, Africa and Latin America Fexofenadine Sales Quantity by Type (2024-2034) & (K Units)
Table 106. Middle East, Africa and Latin America Fexofenadine Revenue by Type (2018-2023) & (US$ Million)
Table 107. Middle East, Africa and Latin America Fexofenadine Revenue by Type (2024-2034) & (US$ Million)
Table 108. Middle East, Africa and Latin America Fexofenadine Sales Quantity by Application (2018-2023) & (K Units)
Table 109. Middle East, Africa and Latin America Fexofenadine Sales Quantity by Application (2024-2034) & (K Units)
Table 110. Middle East, Africa and Latin America Fexofenadine Revenue by Application (2018-2023) & (US$ Million)
Table 111. Middle East, Africa and Latin America Fexofenadine Revenue by Application (2024-2034) & (US$ Million)
Table 112. Middle East, Africa and Latin America Fexofenadine Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 113. Middle East, Africa and Latin America Fexofenadine Revenue by Country (2018-2023) & (US$ Million)
Table 114. Middle East, Africa and Latin America Fexofenadine Revenue by Country (2024-2034) & (US$ Million)
Table 115. Middle East, Africa and Latin America Fexofenadine Sales Quantity by Country (2018-2023) & (K Units)
Table 116. Middle East, Africa and Latin America Fexofenadine Sales Quantity by Country (2024-2034) & (K Units)
Table 117. Viruj Pharma Company Information
Table 118. Viruj Pharma Description and Overview
Table 119. Viruj Pharma Fexofenadine Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 120. Viruj Pharma Fexofenadine Product and Services
Table 121. Viruj Pharma Fexofenadine SWOT Analysis
Table 122. Viruj Pharma Recent Developments
Table 123. Cemex Pharma Company Information
Table 124. Cemex Pharma Description and Overview
Table 125. Cemex Pharma Fexofenadine Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 126. Cemex Pharma Fexofenadine Product and Services
Table 127. Cemex Pharma Fexofenadine SWOT Analysis
Table 128. Cemex Pharma Recent Developments
Table 129. Smaart Pharmaceutticals Company Information
Table 130. Smaart Pharmaceutticals Description and Overview
Table 131. Smaart Pharmaceutticals Fexofenadine Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 132. Smaart Pharmaceutticals Fexofenadine Product and Services
Table 133. Smaart Pharmaceutticals Fexofenadine SWOT Analysis
Table 134. Smaart Pharmaceutticals Recent Developments
Table 135. Titan Pharma Company Information
Table 136. Titan Pharma Description and Overview
Table 137. Titan Pharma Fexofenadine Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 138. Titan Pharma Fexofenadine Product and Services
Table 139. Titan Pharma Fexofenadine SWOT Analysis
Table 140. Titan Pharma Recent Developments
Table 141. AFCL Company Information
Table 142. AFCL Description and Overview
Table 143. AFCL Fexofenadine Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 144. AFCL Fexofenadine Product and Services
Table 145. AFCL Fexofenadine SWOT Analysis
Table 146. AFCL Recent Developments
Table 147. Synkromax Company Information
Table 148. Synkromax Description and Overview
Table 149. Synkromax Fexofenadine Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 150. Synkromax Fexofenadine Product and Services
Table 151. Synkromax Fexofenadine SWOT Analysis
Table 152. Synkromax Recent Developments
Table 153. Farmhispania Company Information
Table 154. Farmhispania Description and Overview
Table 155. Farmhispania Fexofenadine Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 156. Farmhispania Fexofenadine Product and Services
Table 157. Farmhispania Fexofenadine SWOT Analysis
Table 158. Farmhispania Recent Developments
Table 159. Gen Pharma Company Information
Table 160. Gen Pharma Description and Overview
Table 161. Gen Pharma Fexofenadine Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 162. Gen Pharma Fexofenadine Product and Services
Table 163. Gen Pharma Fexofenadine SWOT Analysis
Table 164. Gen Pharma Recent Developments
Table 165. Admiron Life Sciences Private Limited Company Information
Table 166. Admiron Life Sciences Private Limited Description and Overview
Table 167. Admiron Life Sciences Private Limited Fexofenadine Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 168. Admiron Life Sciences Private Limited Fexofenadine Product and Services
Table 169. Admiron Life Sciences Private Limited Fexofenadine SWOT Analysis
Table 170. Admiron Life Sciences Private Limited Recent Developments
Table 171. JRC Company Information
Table 172. JRC Description and Overview
Table 173. JRC Fexofenadine Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 174. JRC Fexofenadine Product and Services
Table 175. JRC Fexofenadine SWOT Analysis
Table 176. JRC Recent Developments
Table 177. Archerchem Company Information
Table 178. Archerchem Description and Overview
Table 179. Archerchem Fexofenadine Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 180. Archerchem Fexofenadine Product and Services
Table 181. Archerchem Recent Developments
Table 182. Sibram Company Information
Table 183. Sibram Description and Overview
Table 184. Sibram Fexofenadine Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 185. Sibram Fexofenadine Product and Services
Table 186. Sibram Recent Developments
Table 187. Sumitomo Chemical Company Information
Table 188. Sumitomo Chemical Description and Overview
Table 189. Sumitomo Chemical Fexofenadine Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 190. Sumitomo Chemical Fexofenadine Product and Services
Table 191. Sumitomo Chemical Recent Developments
Table 192. Panchsheel Company Information
Table 193. Panchsheel Description and Overview
Table 194. Panchsheel Fexofenadine Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 195. Panchsheel Fexofenadine Product and Services
Table 196. Panchsheel Recent Developments
Table 197. CAMEO HEALTH CARE Company Information
Table 198. CAMEO HEALTH CARE Description and Overview
Table 199. CAMEO HEALTH CARE Fexofenadine Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 200. CAMEO HEALTH CARE Fexofenadine Product and Services
Table 201. CAMEO HEALTH CARE Recent Developments
Table 202. CEPiA-Sanofi Company Information
Table 203. CEPiA-Sanofi Description and Overview
Table 204. CEPiA-Sanofi Fexofenadine Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 205. CEPiA-Sanofi Fexofenadine Product and Services
Table 206. CEPiA-Sanofi Recent Developments
Table 207. Va Sudha Pharma Chem Limited Company Information
Table 208. Va Sudha Pharma Chem Limited Description and Overview
Table 209. Va Sudha Pharma Chem Limited Fexofenadine Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 210. Va Sudha Pharma Chem Limited Fexofenadine Product and Services
Table 211. Va Sudha Pharma Chem Limited Recent Developments
Table 212. VPL Chemicals Company Information
Table 213. VPL Chemicals Description and Overview
Table 214. VPL Chemicals Fexofenadine Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 215. VPL Chemicals Fexofenadine Product and Services
Table 216. VPL Chemicals Recent Developments
Table 217. Zhejiang Excel Pharmaceutical Company Information
Table 218. Zhejiang Excel Pharmaceutical Description and Overview
Table 219. Zhejiang Excel Pharmaceutical Fexofenadine Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 220. Zhejiang Excel Pharmaceutical Fexofenadine Product and Services
Table 221. Zhejiang Excel Pharmaceutical Recent Developments
Table 222. Key Raw Materials Lists
Table 223. Raw Materials Key Suppliers Lists
Table 224. Fexofenadine Distributors List
Table 225. Fexofenadine Customers List
Table 226. Fexofenadine Market Trends
Table 227. Fexofenadine Market Drivers
Table 228. Fexofenadine Market Challenges
Table 229. Fexofenadine Market Restraints
Table 230. Research Programs/Design for This Report
Table 231. Key Data Information from Secondary Sources
Table 232. Key Data Information from Primary Sources
List of Figures
Figure 1. Fexofenadine Product Picture
Figure 2. Global Fexofenadine Market Size Growth Rate by Type, 2018 VS 2024 VS 2034 (US$ Million)
Figure 3. Global Fexofenadine Market Share by Type in 2024 & 2034
Figure 4. Purity:98% Product Picture
Figure 5. Purity:Above 98% Product Picture
Figure 6. Global Fexofenadine Market Size Growth Rate by Application, 2018 VS 2024 VS 2034 (US$ Million)
Figure 7. Global Fexofenadine Market Share by Application in 2024 & 2034
Figure 8. Hay Fever Treatment
Figure 9. Urticaria Treatment
Figure 10. Fexofenadine Report Years Considered
Figure 11. Global Fexofenadine Revenue, (US$ Million), 2018 VS 2024 VS 2034
Figure 12. Global Fexofenadine Revenue 2018-2034 (US$ Million)
Figure 13. Global Fexofenadine Revenue Market Share by Region in Percentage: 2024 Versus 2034
Figure 14. Global Fexofenadine Sales Quantity 2018-2034 (K Units)
Figure 15. Global Fexofenadine Sales Quantity Market Share by Region (2018-2023)
Figure 16. Global Fexofenadine Sales Quantity Market Share by Region (2024-2034)
Figure 17. North America Fexofenadine Sales Quantity YoY (2018-2034) & (K Units)
Figure 18. North America Fexofenadine Revenue YoY (2018-2034) & (US$ Million)
Figure 19. Europe Fexofenadine Sales Quantity YoY (2018-2034) & (K Units)
Figure 20. Europe Fexofenadine Revenue YoY (2018-2034) & (US$ Million)
Figure 21. China Fexofenadine Sales Quantity YoY (2018-2034) & (K Units)
Figure 22. China Fexofenadine Revenue YoY (2018-2034) & (US$ Million)
Figure 23. APAC Fexofenadine Sales Quantity YoY (2018-2034) & (K Units)
Figure 24. APAC Fexofenadine Revenue YoY (2018-2034) & (US$ Million)
Figure 25. Middle East, Africa and Latin America Fexofenadine Sales Quantity YoY (2018-2034) & (K Units)
Figure 26. Middle East, Africa and Latin America Fexofenadine Revenue YoY (2018-2034) & (US$ Million)
Figure 27. The Top 10 and Top 5 Players Market Share by Fexofenadine Sales Quantity in 2024
Figure 28. The Top 10 and Top 5 Players Market Share by Fexofenadine Revenue in 2024
Figure 29. Fexofenadine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2024
Figure 30. Global Fexofenadine Sales Quantity Market Share by Type (2018-2034)
Figure 31. Global Fexofenadine Revenue Market Share by Type (2018-2034)
Figure 32. Global Fexofenadine Sales Quantity Market Share by Application (2018-2034)
Figure 33. Global Fexofenadine Revenue Market Share by Application (2018-2034)
Figure 34. North America Fexofenadine Revenue Market Share by Company in 2024
Figure 35. North America Fexofenadine Sales Quantity Market Share by Company in 2024
Figure 36. North America Fexofenadine Sales Quantity Market Share by Type (2018-2034)
Figure 37. North America Fexofenadine Revenue Market Share by Type (2018-2034)
Figure 38. North America Fexofenadine Sales Quantity Market Share by Application (2018-2034)
Figure 39. North America Fexofenadine Revenue Market Share by Application (2018-2034)
Figure 40. North America Fexofenadine Revenue Share by Country (2018-2034)
Figure 41. North America Fexofenadine Sales Quantity Share by Country (2018-2034)
Figure 42. U.S. Fexofenadine Revenue (2018-2034) & (US$ Million)
Figure 43. Canada Fexofenadine Revenue (2018-2034) & (US$ Million)
Figure 44. Europe Fexofenadine Sales Quantity Market Share by Company in 2024
Figure 45. Europe Fexofenadine Revenue Market Share by Company in 2024
Figure 46. Europe Fexofenadine Sales Quantity Market Share by Type (2018-2034)
Figure 47. Europe Fexofenadine Revenue Market Share by Type (2018-2034)
Figure 48. Europe Fexofenadine Sales Quantity Market Share by Application (2018-2034)
Figure 49. Europe Fexofenadine Revenue Market Share by Application (2018-2034)
Figure 50. Europe Fexofenadine Revenue Share by Country (2018-2034)
Figure 51. Europe Fexofenadine Sales Quantity Share by Country (2018-2034)
Figure 52. Germany Fexofenadine Revenue (2018-2034) & (US$ Million)
Figure 53. France Fexofenadine Revenue (2018-2034) & (US$ Million)
Figure 54. U.K. Fexofenadine Revenue (2018-2034) & (US$ Million)
Figure 55. Italy Fexofenadine Revenue (2018-2034) & (US$ Million)
Figure 56. Russia Fexofenadine Revenue (2018-2034) & (US$ Million)
Figure 57. China Fexofenadine Sales Quantity Market Share by Company in 2024
Figure 58. China Fexofenadine Revenue Market Share by Company in 2024
Figure 59. China Fexofenadine Sales Quantity Market Share by Type (2018-2034)
Figure 60. China Fexofenadine Revenue Market Share by Type (2018-2034)
Figure 61. China Fexofenadine Sales Quantity Market Share by Application (2018-2034)
Figure 62. China Fexofenadine Revenue Market Share by Application (2018-2034)
Figure 63. APAC Fexofenadine Sales Quantity Market Share by Company in 2024
Figure 64. APAC Fexofenadine Revenue Market Share by Company in 2024
Figure 65. APAC Fexofenadine Sales Quantity Market Share by Type (2018-2034)
Figure 66. APAC Fexofenadine Revenue Market Share by Type (2018-2034)
Figure 67. APAC Fexofenadine Sales Quantity Market Share by Application (2018-2034)
Figure 68. APAC Fexofenadine Revenue Market Share by Application (2018-2034)
Figure 69. APAC Fexofenadine Revenue Share by Region (2018-2034)
Figure 70. APAC Fexofenadine Sales Quantity Share by Region (2018-2034)
Figure 71. Japan Fexofenadine Revenue (2018-2034) & (US$ Million)
Figure 72. South Korea Fexofenadine Revenue (2018-2034) & (US$ Million)
Figure 73. China Taiwan Fexofenadine Revenue (2018-2034) & (US$ Million)
Figure 74. Southeast Asia Fexofenadine Revenue (2018-2034) & (US$ Million)
Figure 75. India Fexofenadine Revenue (2018-2034) & (US$ Million)
Figure 76. Middle East, Africa and Latin America Fexofenadine Sales Quantity Market Share by Company in 2024
Figure 77. Middle East, Africa and Latin America Fexofenadine Revenue Market Share by Company in 2024
Figure 78. Middle East, Africa and Latin America Fexofenadine Sales Quantity Market Share by Type (2018-2034)
Figure 79. Middle East, Africa and Latin America Fexofenadine Revenue Market Share by Type (2018-2034)
Figure 80. Middle East, Africa and Latin America Fexofenadine Sales Quantity Market Share by Application (2018-2034)
Figure 81. Middle East, Africa and Latin America Fexofenadine Revenue Market Share by Application (2018-2034)
Figure 82. Middle East, Africa and Latin America Fexofenadine Sales Quantity Share by Country (2018-2034)
Figure 83. Middle East, Africa and Latin America Fexofenadine Revenue Share by Country (2018-2034)
Figure 84. Brazil Fexofenadine Revenue (2018-2034) & (US$ Million)
Figure 85. Mexico Fexofenadine Revenue (2018-2034) & (US$ Million)
Figure 86. Turkey Fexofenadine Revenue (2018-2034) & (US$ Million)
Figure 87. Israel Fexofenadine Revenue (2018-2034) & (US$ Million)
Figure 88. GCC Countries Fexofenadine Revenue (2018-2034) & (US$ Million)
Figure 89. Fexofenadine Value Chain
Figure 90. Fexofenadine Production Process
Figure 91. Channels of Distribution (Direct Vs Distribution)
Figure 92. Distributors Profiles
Figure 93. Bottom-up and Top-down Approaches for This Report
Figure 94. Data Triangulation
Figure 95. Key Executives Interviewed